On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Karl Herholz

ResearcherPublications, citations & collaboration network

Karl Herholz is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Karl Herholz have?

ScholarIQindexed works

Karl Herholz has 491 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Karl Herholz have?

ScholarIQcitation count

Karl Herholz has 26,810 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Karl Herholz?

ScholarIQh-index

Karl Herholz has an h-index of 89 in OpenAlex.

What is the i10-index of Karl Herholz?

ScholarIQi10-index

Karl Herholz has an i10-index of 248 in OpenAlex.

What is the ORCID of Karl Herholz?

ScholarIQorcid

The ORCID for Karl Herholz is on the source record.

What is the OpenAlex record for Karl Herholz?

ScholarIQopenalex

The OpenAlex for Karl Herholz is on the source record.

What are the most-cited papers on Karl Herholz?

ScholarIQmost cited works
Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET
Karl Herholz, Éric Salmon, Daniela Perani, Jean‐Claude Baron, Vjera Holthoff‐Detto, Lutz Frölich, Peter Schönknecht, Kengo Ito, R. Mielke, Elke Kalbe
NeuroImage. 2002839 CitationsOPEN ACCESS
Multicenter Standardized <sup>18</sup>F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias
Lisa Mosconi, Wai Hon Tsui, Karl Herholz, Alberto Pupi, Alexander Drzezga, Giovanni Lucignani, Eric M. Reiman, Vjera Holthoff‐Detto, Elke Kalbe, Sandro Sorbi, Janine Diehl‐Schmid, Robert Perneczky, Francesca Clerici, Richard J. Caselli, Bettina Beuthien‐Baumann, Alexander Kurz, Satoshi Minoshima, Mony J. de Leon
Journal of Nuclear Medicine. 2008729 CitationsOPEN ACCESS
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
Giovanni B. Frisoni, Marina Boccardi, Frederik Barkhof, Kaj Blennow, Stefano F. Cappa, Konstantinos Chiotis, Jean‐François Démonet, Valentina Garibotto, Pantéleimon Giannakopoulos, Anton Gietl, Oskar Hansson, Karl Herholz, Clifford R. Jack, Flavio Nobili, Agneta Nordberg, Heather M. Snyder, Mara ten Kate, Andrea Varrone, Emiliano Albanese, Stefanie Becker, Patrick M. Bossuyt, María C. Carrillo, Chiara Cerami, Bruno Dubois, V. Gallo, Ezio Giacobini, Gabriel Gold, Samia Hurst, Anders Lönneborg, Karl‐Olof Lövblad, Niklas Mattsson, José Luís Molinuevo, Andreas U. Monsch, Urs P. Mosimann, Alessandro Padovani, Agnese Picco, Corinna Porteri, Osman Ratib, Laure Saint‐Aubert, Charles Scerri, Philip Scheltens, Jonathan M. Schott, Ida Sonni, Stefan Teipel, Paolo Vineis, Pieter Jelle Visser, Yutaka Yasui, Bengt Winblad
The Lancet Neurology. 2017634 CitationsOPEN ACCESS
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
Harald Hampel, Richard Frank, Karl Broich, Stefan Teipel, Russell Katz, John Hardy, Karl Herholz, Arun L.W. Bokde, Frank Jessen, Yvonne C. Hoessler, Wendy R. Sanhai, Henrik Zetterberg, Janet Woodcock, Kaj Blennow
Nature Reviews Drug Discovery. 2010633 Citations

Related on ScholarIQ

470M+ articles · free account